Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Coal Township › NPI 1033491741
Clinic

Geisinger Medical Center

Geisinger Medical Center was paid $4.65M by Medicaid between Oct 2019 and Dec 2024, across 165 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.

33Billing provider infoGEISINGER MEDICAL CENTER
COAL TOWNSHIP, PA 17866
33aNPI1033491741assigned 09/20/2011
33bProvider typeClinic/Center
28Total paid$4.65M
24GClaims115,346
24DCodes billed165
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers

Next to other Clinic/Center providers in Pennsylvania

Rank by total paid#34 of 176
Median peer was paid$441K
This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019150$2K
20208,326$231K
202145,427$1.43M
202219,388$1.02M
202317,749$974K
2024incomplete24,306$1.00M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 9,308 8,918 $1.09M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 19% 5,438 5,199 $864K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 18% 10,648 10,252 $856K
0202U Oncology (prostate), multianalyte, gene expression profiling 16% 3,405 3,289 $764K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.8% 2,263 2,217 $86K
80053 Comprehensive metabolic panel 1.7% 8,128 7,739 $81K
77067 Screening mammography, bilateral, including computer-aided detection 1.5% 721 717 $69K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.5% 356 350 $68K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.2% 690 684 $57K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 11,267 10,670 $56K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.1% 1,850 1,782 $52K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 398 394 $30K
153 more codes
84443 Thyroid stimulating hormone (TSH) <1% 1,310 $27K
87631 <1% 250 $26K
T1015 A visit at a community health center or clinic (one all-in rate) <1% 537 $26K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,432 $26K
0100U <1% 57 $25K
71046 Radiologic examination, chest; 2 views <1% 1,359 $22K
84702 <1% 1,481 $21K
76830 Ultrasound, transvaginal <1% 315 $21K
80061 Lipid panel <1% 1,357 $18K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 2,017 $16K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 319 $16K
70450 Computed tomography, head or brain; without contrast material <1% 205 $15K
80048 Basic metabolic panel (calcium, ionized) <1% 2,127 $15K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 304 $15K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 395 $14K
84484 <1% 1,605 $13K
96361 Intravenous infusion, hydration; each additional hour <1% 1,104 $13K
90670 <1% 190 $12K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 831 $10K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 208 $10K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 92 $9K
36415 Collection of venous blood by venipuncture <1% 5,841 $8K
76770 <1% 118 $8K
96375 Therapeutic injection; each additional sequential IV push <1% 456 $7K
83690 <1% 1,702 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 954 $6K
76536 <1% 85 $6K
83605 <1% 843 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 150 $5K
71045 Radiologic examination, chest; single view <1% 496 $5K
90723 <1% 98 $5K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 256 $5K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 254 $5K
87086 Culture, bacterial; quantitative colony count, urine <1% 675 $4K
85027 <1% 782 $4K
76642 <1% 95 $4K
83880 <1% 174 $4K
82805 <1% 160 $4K
81001 <1% 1,531 $4K
87481 <1% 54 $4K
Q3014 Telehealth originating site facility fee <1% 318 $3K
90715 <1% 507 $3K
G0009 Administration of pneumococcal vaccine <1% 208 $3K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 14 $3K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 25 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 305 $3K
90680 <1% 81 $3K
90686 <1% 215 $3K
90472 Immunization administration, each additional vaccine (list separately) <1% 201 $3K
73564 <1% 214 $3K
72100 <1% 141 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,950 $2K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 25 $2K
73630 <1% 369 $2K
73030 <1% 222 $2K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 65 $2K
73610 <1% 231 $2K
82607 <1% 188 $2K
85610 <1% 692 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 111 $2K
82728 <1% 185 $2K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 17 $2K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $2K
90647 <1% 108 $2K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 50 $2K
G0008 Administration of influenza virus vaccine <1% 165 $2K
83540 <1% 208 $2K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 70 $2K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 12 $2K
85379 <1% 206 $2K
83735 <1% 316 $1K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 54 $1K
77065 Tomosynthesis, mammo <1% 14 $1K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 57 $1K
81003 <1% 592 $1K
86803 <1% 99 $1K
87430 <1% 217 $1K
73110 <1% 176 $1K
84439 <1% 137 $1K
73130 <1% 204 $1K
86140 <1% 467 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 40 $1K
87511 <1% 52 $946.73
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 106 $923.82
81025 <1% 349 $886.80
86900 <1% 216 $836.37
20610 <1% 62 $827.86
90633 <1% 13 $810.55
83655 <1% 77 $788.60
83550 <1% 169 $780.44
86850 <1% 197 $744.96
82375 <1% 162 $714.64
87186 <1% 117 $653.83
82570 <1% 97 $617.01
82248 <1% 108 $604.80
71250 <1% 13 $601.18
72125 Computed tomography, cervical spine; without contrast material <1% 14 $562.44
86901 <1% 216 $546.07
82962 <1% 425 $535.59
87150 <1% 12 $460.55
90473 <1% 45 $460.20
83050 <1% 160 $445.80
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,719 $419.34
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 13 $404.91
85652 <1% 133 $321.09
86618 <1% 14 $303.68
74018 <1% 30 $301.37
72040 <1% 15 $299.56
80076 <1% 49 $289.41
84100 <1% 68 $274.66
73080 <1% 44 $274.51
87340 <1% 39 $228.77
73502 <1% 12 $226.61
86780 <1% 13 $208.78
A9585 Injection, gadobutrol, 0.1 ml <1% 276 $206.14
82565 <1% 44 $199.95
J2704 Injection, propofol, 10 mg <1% 1,384 $181.24
85007 <1% 42 $154.42
90474 <1% 13 $131.50
83525 <1% 14 $131.23
87077 <1% 30 $125.28
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,505 $108.40
J2270 Injection, morphine sulfate, up to 10 mg <1% 47 $108.08
82043 <1% 13 $101.76
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,124 $97.12
86762 <1% 12 $90.36
73090 <1% 13 $89.95
J1790 Injection, droperidol, up to 5 mg <1% 98 $85.42
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,418 $84.69
94664 <1% 13 $67.95
J0690 Injection, cefazolin sodium, 500 mg <1% 260 $59.10
84460 <1% 13 $50.66
86592 <1% 12 $50.40
84450 <1% 13 $50.13
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,082 $50.03
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 13 $47.71
J1170 Injection, hydromorphone, up to 4 mg <1% 73 $45.86
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 933 $10.96
J3475 Injection, magnesium sulfate, per 500 mg <1% 25 $10.37
C9290 Injection, bupivacaine liposome, 1 mg 0% 13 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 12 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 209 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 51 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 73 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 12 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 27 $0.00
90656 0% 13 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 148 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 0% 152 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 41 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 91 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 38 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 58 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCERMINARO, DANIELLE (VP AND CFO)